Literature DB >> 31725312

The Time Is Now to End the HIV Epidemic.

Brett P Giroir1.   

Abstract

In his State of the Union Address on February 5, 2019, President Donald J. Trump announced his administration's goal to end the domestic HIV epidemic. Following the announcement of the Ending the HIV Epidemic: A Plan for America initiative, the president proposed $291 million in new funding for the fiscal year 2020 Department of Health and Human Services (HHS) budget to implement a new initiative to reduce the number of new HIV infections by 75% in the next five years (2025) and by 90% in the next 10 years (2030). This is in addition to the $20 billion the US government already spends each year, domestically, for HIV prevention and care.With this initiative, HHS recognizes that the time to end the HIV epidemic is now: we have the right data, the right biomedical and behavioral tools, and the right leadership. With the new resources, the goal is achievable.This article outlines how this initiative will be accomplished through the implementation of four fundamental strategies that will be tailored by local communities on the basis of their own needs and strengths.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31725312      PMCID: PMC6893354          DOI: 10.2105/AJPH.2019.305380

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  7 in total

1.  Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study.

Authors:  Benjamin R Bavinton; Angie N Pinto; Nittaya Phanuphak; Beatriz Grinsztejn; Garrett P Prestage; Iryna B Zablotska-Manos; Fengyi Jin; Christopher K Fairley; Richard Moore; Norman Roth; Mark Bloch; Catherine Pell; Anna M McNulty; David Baker; Jennifer Hoy; Ban Kiem Tee; David J Templeton; David A Cooper; Sean Emery; Anthony Kelleher; Andrew E Grulich
Journal:  Lancet HIV       Date:  2018-07-17       Impact factor: 12.767

2.  Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

Authors:  Jens D Lundgren; Abdel G Babiker; Fred Gordin; Sean Emery; Birgit Grund; Shweta Sharma; Anchalee Avihingsanon; David A Cooper; Gerd Fätkenheuer; Josep M Llibre; Jean-Michel Molina; Paula Munderi; Mauro Schechter; Robin Wood; Karin L Klingman; Simon Collins; H Clifford Lane; Andrew N Phillips; James D Neaton
Journal:  N Engl J Med       Date:  2015-07-20       Impact factor: 91.245

3.  A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.

Authors:  Christine Danel; Raoul Moh; Delphine Gabillard; Anani Badje; Jérôme Le Carrou; Timothée Ouassa; Eric Ouattara; Amani Anzian; Jean-Baptiste Ntakpé; Albert Minga; Gérard M Kouame; Franck Bouhoussou; Arlette Emieme; Antoine Kouamé; André Inwoley; Thomas-d'Aquin Toni; Hugues Ahiboh; Mathieu Kabran; Cyprien Rabe; Baba Sidibé; Gustave Nzunetu; Romuald Konan; Joachim Gnokoro; Patrice Gouesse; Eugène Messou; Lambert Dohoun; Synali Kamagate; Abo Yao; Solange Amon; Amadou-Barenson Kouame; Aboli Koua; Emmanuel Kouamé; Yao Ndri; Olivier Ba-Gomis; Marcelle Daligou; Simplice Ackoundzé; Denise Hawerlander; Alex Ani; Fassery Dembélé; Fatoumata Koné; Calixte Guéhi; Constance Kanga; Serge Koule; Jonas Séri; Mykayila Oyebi; Nathalie Mbakop; Olewole Makaila; Carole Babatunde; Nathanael Babatounde; Gisèle Bleoué; Mireille Tchoutedjem; Alain-Claude Kouadio; Ghislaine Sena; Sahinou-Yediga Yededji; Rodrigue Assi; Alima Bakayoko; Alassane Mahassadi; Alain Attia; Armel Oussou; Max Mobio; Doféré Bamba; Mesmin Koman; Apollinaire Horo; Nina Deschamps; Henri Chenal; Madeleine Sassan-Morokro; Seidou Konate; Kakou Aka; Eba Aoussi; Valérie Journot; Célestin Nchot; Sophie Karcher; Marie-Laure Chaix; Christine Rouzioux; Papa-Salif Sow; Christian Perronne; Pierre-Marie Girard; Hervé Menan; Emmanuel Bissagnene; Auguste Kadio; Virginie Ettiegne-Traore; Corinne Moh-Semdé; Abo Kouame; Jean-Marie Massumbuko; Geneviève Chêne; Mireille Dosso; Serge K Domoua; Thérèse N'Dri-Yoman; Roger Salamon; Serge P Eholié; Xavier Anglaret
Journal:  N Engl J Med       Date:  2015-07-20       Impact factor: 91.245

4.  Estimation of HIV incidence in the United States.

Authors:  H Irene Hall; Ruiguang Song; Philip Rhodes; Joseph Prejean; Qian An; Lisa M Lee; John Karon; Ron Brookmeyer; Edward H Kaplan; Matthew T McKenna; Robert S Janssen
Journal:  JAMA       Date:  2008-08-06       Impact factor: 56.272

5.  Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.

Authors:  Alison J Rodger; Valentina Cambiano; Tina Bruun; Pietro Vernazza; Simon Collins; Jan van Lunzen; Giulio Maria Corbelli; Vicente Estrada; Anna Maria Geretti; Apostolos Beloukas; David Asboe; Pompeyo Viciana; Félix Gutiérrez; Bonaventura Clotet; Christian Pradier; Jan Gerstoft; Rainer Weber; Katarina Westling; Gilles Wandeler; Jan M Prins; Armin Rieger; Marcel Stoeckle; Tim Kümmerle; Teresa Bini; Adriana Ammassari; Richard Gilson; Ivanka Krznaric; Matti Ristola; Robert Zangerle; Pia Handberg; Antonio Antela; Sris Allan; Andrew N Phillips; Jens Lundgren
Journal:  JAMA       Date:  2016-07-12       Impact factor: 56.272

6.  Vital Signs: Human Immunodeficiency Virus Testing and Diagnosis Delays - United States.

Authors:  Andre F Dailey; Brooke E Hoots; H Irene Hall; Ruiguang Song; Demorah Hayes; Paul Fulton; Joseph Prejean; Angela L Hernandez; Linda J Koenig; Linda A Valleroy
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-12-01       Impact factor: 17.586

7.  Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.

Authors:  Alison J Rodger; Valentina Cambiano; Tina Bruun; Pietro Vernazza; Simon Collins; Olaf Degen; Giulio Maria Corbelli; Vicente Estrada; Anna Maria Geretti; Apostolos Beloukas; Dorthe Raben; Pep Coll; Andrea Antinori; Nneka Nwokolo; Armin Rieger; Jan M Prins; Anders Blaxhult; Rainer Weber; Arne Van Eeden; Norbert H Brockmeyer; Amanda Clarke; Jorge Del Romero Guerrero; Francois Raffi; Johannes R Bogner; Gilles Wandeler; Jan Gerstoft; Felix Gutiérrez; Kees Brinkman; Maria Kitchen; Lars Ostergaard; Agathe Leon; Matti Ristola; Heiko Jessen; Hans-Jürgen Stellbrink; Andrew N Phillips; Jens Lundgren
Journal:  Lancet       Date:  2019-05-02       Impact factor: 79.321

  7 in total
  20 in total

1.  What Will It Take to End HIV in the United States? : A Comprehensive, Local-Level Modeling Study.

Authors:  Anthony Todd Fojo; Melissa Schnure; Parastu Kasaie; David W Dowdy; Maunank Shah
Journal:  Ann Intern Med       Date:  2021-09-21       Impact factor: 25.391

2.  Health Care Providers' Views on Clinic Infrastructure and Practice Models That May Facilitate HIV Preexposure Prophylaxis (PrEP) Prescribing: A Qualitative Meta-Synthesis.

Authors:  Yuko Mizuno; Deborah J Gelaude; Nicole Crepaz; Emiko Kamitani; Julia B DeLuca; Carolyn A Leighton; Megan E Wichser; Dawn K Smith
Journal:  Health Promot Pract       Date:  2021-09-22

3.  Projected Impact of Expanded Long-Acting Injectable PrEP Use Among Men Who Have Sex With Men on Local HIV Epidemics.

Authors:  Ruchita Balasubramanian; Parastu Kasaie; Melissa Schnure; David W Dowdy; Maunank Shah; Anthony Todd Fojo
Journal:  J Acquir Immune Defic Syndr       Date:  2022-10-01       Impact factor: 3.771

4.  Impacts of Medicaid Expansion on Health Insurance and Coverage Transitions among Women with or at Risk for HIV in the United States.

Authors:  Andrew Edmonds; Nadya Belenky; Adebola A Adedimeji; Mardge H Cohen; Gina Wingood; Margaret A Fischl; Elizabeth T Golub; Mallory O Johnson; Daniel Merenstein; Joel Milam; Deborah Konkle-Parker; Tracey E Wilson; Adaora A Adimora
Journal:  Womens Health Issues       Date:  2022-05-11

5.  Texting Lost-to-follow-up PrEP Patients from a San Francisco Sexual Health Clinic.

Authors:  Kelly A Johnson; Montica Levy; Hannah Brosnan; Robert P Kohn; Stephanie E Cohen
Journal:  Prev Sci       Date:  2022-07-16

6.  Snap out stigma photovoice project in the U.S. South.

Authors:  Latrice C Pichon; Andrea Williams Stubbs; Michelle Teti
Journal:  BMC Health Serv Res       Date:  2022-06-20       Impact factor: 2.908

7.  Brief Report: HIV Pre-exposure Prophylaxis Prescribing in an Urban Safety-Net Health System.

Authors:  Afiba Manza-A Agovi; Ifedioranma Anikpo; Matthew J Cvitanovich; Esther O Fasanmi; Rohit P Ojha; Julia L Marcus
Journal:  J Acquir Immune Defic Syndr       Date:  2021-11-01       Impact factor: 3.771

Review 8.  Ending the HIV epidemic for all, not just some: structural racism as a fundamental but overlooked social-structural determinant of the US HIV epidemic.

Authors:  Lisa Bowleg; Arianne N Malekzadeh; Mary Mbaba; Cheriko A Boone
Journal:  Curr Opin HIV AIDS       Date:  2022-03-01       Impact factor: 4.061

9.  Graves' Disease in a Patient With Human Immunodeficiency Virus Infection as an Immune Reconstitution Inflammatory Syndrome.

Authors:  Sarah Ayad; Kirolos Gergis; Noreen Mirza; Mohammad Nabil Rayad; Julius Salamera
Journal:  Cureus       Date:  2021-06-01

10.  Healthcare stigma and HIV risk among rural people who inject drugs.

Authors:  Hilary L Surratt; Janet K Otachi; Christopher J McLouth; Nikita Vundi
Journal:  Drug Alcohol Depend       Date:  2021-06-25       Impact factor: 4.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.